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Identification of patients at high risk of negative
psychological consequences associated with
BRCA1 mutation
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Genetic studies of hereditary predisposition to cancer
are becoming more accessible and acceptable form of
cancer prevention. However, it is suggested that there is
a potential impact of diagnosed high risk of developing
cancer on the psychological functioning of patients.
Research on this subject has been carried out in other
countries, while in Poland similar studies using psycho-
logical tests have not been conducted so far. The objec-
tives of the research were:
1. psychological assessment of patients before under-
going of genetic test diagnosing high predisposition to
breast cancer or ovarian cancer (BRCA1 test),
2. assessment of psychological reactions of patients
after receiving of the positive BRCA1 test result,
3. evaluation of the usefulness of selected psychologi-
cal tests for identification of patients likely to respond
by excessive psychological distress to the positive
BRCA1 test result.
It was found that the average level of trait anxiety
among BRCA1 carriers before receiving the genetic test
result was 5.6, and the level of basic hope - 6.0 and
these values are within the population standards for
these tests. The average level of state anxiety was only
slightly above normal - 6.7. There were no differences
between female patients suffering from cancer and
healthy ones. The average level of state anxiety mea-
sured one month after receiving the genetic test result
increases slightly and after a year - drops slightly below
the state before the genetic test - both in groups of peo-
ple suffering from cancer, and healthy ones (although
not statistically significant). The negative psychological
reaction to an abnormal genetic test result measured by
the IES test (post-test1 after one month) is significantly
higher in patients with diagnosed cancer compared to
healthy subjects (p=0.0008). The high level of state anxi-
ety (standard ten: 9 and 10) measured prior to obtaining
genetic test result was found in 18% of BRCA1 mutation
carriers. Statistically significant correlation has been
registered between the level of state anxiety and trait
anxiety measured prior to obtaining genetic test result
and the level of state anxiety measured after one month
(p=0.00001) and after one year (p=0.00001) and the
level of negative psychological reaction (p=0.0001) mea-
sured by the IES test one month after obtaining a
genetic test result. Statistically significant negative rela-
tionship has been found between the level of basic hope
measured before obtaining a genetic test result and the
level of state anxiety (p=0.01) and a negative psychologi-
cal reaction IES (p=0.003) measured one month after
obtaining a genetic test result. Such a relationship has
not been demonstrated with the level of state anxiety
measured after a year. One month after receiving of a
genetic test result, 96% of BRCA1 mutation carriers
(135/141) recommended genetic testing to other women
in a similar situation. By one year posttest, practically all
patients recommended genetic testing.
Conclusions
1. BRCA1 mutation carriers do not exhibit increased
constitutional predisposition to excessive negative psy-
chological reactions.
2. There are over ten percent of BRCA1 mutation car-
riers characterized by a particularly high level of anxiety
both before and after undergoing a genetic test that can
obtain special benefit from specialist psychological care.
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tive genetic BRCA1 test result informing about the pre-
disposition to breast and ovarian cancer does not affect
the suffering of long-term anxiety and other negative
psychological reactions.
4. Patients affected by cancer have a higher level of
negative psychological reaction (IES test after one
month) than healthy patients.
5. A result of the measurement of state anxiety by
STAI X1 test before undergoing BRCA1 test is a good
predictor of psychological reactions observed among
BRCA1 mutation carriers after obtaining genetic test
result.
6. A result of the measurement of trait anxiety by
STAI X2 test before undergoing BRCA1 test is a good
predictor of psychological reactions observed among
BRCA1 mutation carriers after obtaining genetic test
result.
7. A result of the measurement of basic hope by BHI-
12 test before undergoing BRCA1 test is a moderately
good predictor of psychological reactions observed in
the short term (one month) after diagnosing a positive
genetic test result, but does not fulfill this role in the
long term (over one year).
8. BRCA1 mutation carriers, both in short and long
term, recommend to undergo genetic testing to women
in similar situations.
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